4-substituted indole and indazole sulfonamido derivatives as parg inhibitors
WO2020243459A1
Thiadiazolyl derivatives as dna polymerase theta inhibitors
WO2020198469A1
Method for treating epidermal growth factor receptor-driven cancers with protein kinase c inhibitors in combination with an egfr-tyrosine kinase inhibitor
WO2020160213A1
Heteroarylmethylene derivatives as dna polymerase theta inhibitors
WO2020160134A1
Acetamido derivatives as dna polymerase theta inhibitors
WO2020146355A1
Treatment of cancer having gnaq or gna11 genetic mutations with protein kinase c inhibitors
WO2020123395A1
2-oxoquinazoline derivatives as methionine adenosyltransferase 2a inhibitors
WO2020018848A1
Methods of culturing and/or expanding stem cells and/or lineage committed progenitor cells using amido compounds
WO2019241802A2
Methods of inhibiting proliferative cells
WO2019236766A1
Methods of culturing and/or expanding stem cells and/or lineage committed progenitor cells using lactam compounds
